# Risk Review

## Primary risk

The main risk is that an authorization decision could be misread as validation execution or as evidence promotion.

## Risk controls

- The selected decision authorizes only a later, separate execution lane.
- This packet does not execute validation or create validation artifacts.
- This packet repeats the non-execution, no-fallback, no-hosted-provider, no-dashboard, no-`/v1/solve`, no-benchmark, no-billing, no-runtime-change, no-external-ledger, and no-evidence-promotion boundaries.
- The Level 2 controlled usage path remains closed.
- The frozen packet remains unmodified.
- Preserved source artifacts remain unmodified.

## Residual caveats

- The later execution lane still must independently obey the frozen packet, local-only boundary, loopback-only boundary, finite-timeout requirement, artifact capture template, redaction policy, review checklist, and stop conditions.
- This packet does not determine whether any future execution artifact passes review.
- This packet does not change `behavior_evidence=false` or promote any controlled usage or frozen-packet evidence.
